FNY Investment Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-2,730
Closed -$13K – 968
2025
Q3
$13K Buy
+2,730
New +$12.1K ﹤0.01% 750
2021
Q1
– Sell
-700
Closed -$7K – 793
2020
Q4
$7K Sell
700
-4,469
-86% -$45.6K ﹤0.01% 611
2020
Q3
$51K Buy
+5,169
New +$52.2K 0.02% 248

Other funds holding SRTA

FNY Investment Advisers's SRTA Position: Q4 2025 in Review

FNY Investment Advisers sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 2,730 shares — an estimated $13K sold.

FNY Investment Advisers first reported a position in SRTA in Q3 2020 and held it in 3 quarters. The position peaked at $51K in Q3 2020. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • FNY Investment Advisers reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 2,730 Strata Critical Medical Inc shares in Q4 2025, an estimated $13K.
  • FNY Investment Advisers first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 3 quarters.
  • FNY Investment Advisers's Strata Critical Medical Inc position peaked at $51K in Q3 2020.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.